Viome acquires Naring Health to further its lead in personalised nutrition and longevity
Viome's acquisition of Naring Health brings together expertise in microbiome analysis, food science, and proteomics from multiple different…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Nov 23
Viome's acquisition of Naring Health brings together expertise in microbiome analysis, food science, and proteomics from multiple different…
02 Nov 23
VOQUEZNA met the primary endpoints and key secondary superiority endpoints in the pivotal Phase 3 PHALCON-EE trial evaluating…
31 Oct 23
The combined company will start operating from Denver under the new name, Healthpeak Properties, with Healthpeak shareholders owning…
31 Oct 23
The approval was based on the safety and efficacy data from the phase 3 PHALCON-HP trial in which…
30 Oct 23
The FDA approval was based on the findings from the phase 2b VISION-DMD trial in which Agamree met…
30 Oct 23
The US health regulator has asked the consumers not to purchase and immediately stop using the products over…
30 Oct 23
The £100m funding, announced by the Prime Minister, will play a pivotal role in exploring how AI can…
30 Oct 23
RVO is the third indication for Vabysmo, in addition to neovascular or ‘wet’ age-related macular degeneration and diabetic…
30 Oct 23
The MAA is supported by positive data from the Phase 3 MIRASOL trial of ELAHERE in platinum-resistant ovarian…
26 Oct 23
The ACIP panel voted to recommend that 18 years and older individuals with certain risk factors should be…